2025-05-28 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc. (HIMS) based on the data you provided, presented in a structured report with English language and numeric-first approach:

**Report: Hims & Hers Health Inc. (HIMS) - Investment Analysis**

**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 266.49%
*   **VOO Cumulative Return:** 51.51%
*   **Absolute Deviation:** 215.0%
*   **Deviation Range (Max: 292.1, Min: -94.0):**
    *   The current deviation of 215.0 falls within a historical range of -94.0 to 292.1
*   **Relative Deviation:** 80.0%
    *   This indicates that HIMS's outperformance relative to VOO is currently positioned in the upper quartile of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2019-2021  | -46.0% | 51.0% | -90.0%  | -0.0   | 1.5    |
| 2020-2022  | -15.0% | 72.1% | -21.0%  | -0.0   | 1.4    |
| 2021-2023  | -51.0% | 72.1% | -68.0%  | -0.1   | 2.0    |
| 2022-2024  | 127.0% | 78.4% | 110.0%  | -0.2   | 5.4    |
| 2023-2025  | 262.0% | 78.4% | 231.0%  | -0.1   | 11.9   |

*   **Analysis:**
    *   **CAGR:** The Compound Annual Growth Rate (CAGR) shows a highly variable performance, with significant negative growth in earlier periods (2019-2023) but substantial positive growth more recently (2022-2025). The shift to positive CAGR indicates strong recent performance.
    *   **MDD:** The Maximum Drawdown (MDD) is consistently high, around 70-80%, which suggests high volatility and significant potential losses from peak to trough during these periods.
    *   **Alpha:** Alpha values are mostly negative in the early periods (2019-2023), indicating underperformance relative to the benchmark. However, the substantial positive Alpha in the later periods (2022-2025) suggests significant outperformance.
    *   **Beta:** Beta values are generally negative and close to zero, suggesting a weak or inverse correlation with the market. This means HIMS's performance is not strongly tied to broader market movements.
    *   **Cap(B):** Market capitalization has increased significantly from $1.5 billion to $11.9 billion, showing substantial growth in the company's size and market value.

**2. Recent Stock Price Movement**

*   **Current Price:** $53.36
*   **Previous Close:** $54.83
*   **Price Change:** -2.68%
*   **5-Day Moving Average:** $56.18
*   **20-Day Moving Average:** $51.95
*   **60-Day Moving Average:** $38.23

**Analysis:** The stock price has recently decreased. The current price is below the 5-day moving average, indicating a short-term downward trend. However, it's above the 20-day and 60-day moving averages, suggesting an overall upward trend in the medium to long term.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 54.65 (Neutral)
*   **PPO:** -2.38 (Negative Momentum)
*   **Hybrid Signal:** cash_70%_Sell 0.6% of holdings (9 shares - Caution - MRI:0.37)
*   **Delta (20-day Relative Deviation):** -15.9 (Short-term decline)
*   **Expected Return:** -10.8% (Long-term underperformance vs. S&P 500)

**Analysis:**
The MRI suggests a low-risk environment, which is contradictory to the high Volatility, RSI is neutral, while the PPO indicates negative momentum. The hybrid signal suggests a cautious approach with a high cash position and selling a small percentage of holdings. The negative delta confirms the short-term decline. Despite recent outperformance, the expected return projects long-term underperformance compared to the S&P 500.

The recent price change of -2.68% from the previous close indicates a notable downward movement, which should be considered when evaluating the short-term trend.

**4. Recent News & Significant Events**

*   **[2025-05-26]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-27]:** Analysts discussing recent performance and outlook.
*   **[2025-05-28]:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **[2025-05-24]:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests increased volatility and significant events impacting the company. Investors should carefully monitor these developments.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-05-05 | 0.22 | 0.59 B$      |
| 2024-11-04 | 0.35 | 0.40 B$      |
| 2024-08-05 | 0.06 | 0.32 B$      |
| 2024-05-06 | 0.05 | 0.28 B$      |
| 2025-05-05 | 0.05 | 0.28 B$      |

**Analysis:** The EPS and revenue have shown significant growth over the past year. The latest quarter shows a notable increase in both EPS and revenue, indicating strong financial performance.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $0.59B     | 73.50%        |
| 2024-12-31 | $0.48B     | 76.81%        |
| 2024-09-30 | $0.40B     | 79.16%        |
| 2024-06-30 | $0.32B     | 81.30%        |
| 2024-03-31 | $0.28B     | 82.36%        |

**Capital and Profitability**

| Quarter    | Equity     | ROE      |
|------------|------------|----------|
| 2025-03-31 | $0.55B     | 9.01%   |
| 2024-12-31 | $0.48B     | 5.46%   |
| 2024-09-30 | $0.44B     | 17.18%  |
| 2024-06-30 | $0.36B     | 3.67%   |
| 2024-03-31 | $0.34B     | 3.23%   |

**Analysis:**
*   **Revenue and Profitability:** The company has consistently grown its revenue over the past year. However, the profit margin has decreased slightly over the same period, which could be a concern.
*   **Capital and Profitability:** Equity has increased, indicating growth in the company's net assets. ROE (Return on Equity) has fluctuated, with a significant peak in 2024-09-30. The most recent ROE is moderate.

**7. Summary**

Hims & Hers Health Inc. has shown strong recent performance with significant growth in revenue, EPS, and market capitalization. However, the stock exhibits high volatility and recent news points to significant events influencing the company. While it has outperformed the S&P 500 in the past, the expected long-term return is projected to be lower.

**Overall Assessment:**

*   **Positive:** Strong revenue and EPS growth, significant outperformance in recent periods, growing market capitalization.
*   **Negative:** High volatility, decreasing profit margins, negative projected long-term return, recent negative price movement.

**Recommendation:** Given the mixed signals, a cautious approach is warranted. Investors should closely monitor the news and financial data for further developments. The hybrid signal suggests a high cash position, which aligns with this cautious outlook. Further research and due diligence are advised before making any investment decisions.
